William E. Rhodes III

Chair, Founding Member, Third Day Advisors LLC

Bill Rhodes is Founding Member of Third Day Advisors LLC, a management and strategy advisory firm specializing in helping healthcare and life sciences companies as they consider corporate mergers and acquisitions as part of their growth plans. He is also an Operating Partner with Linden Capital Partners LP, a Chicago-based healthcare private equity firm, where he is responsible for the life sciences and diagnostics sector.

Prior, Mr. Rhodes was with Becton Dickinson and Co. (BD), a Fortune 500, multinational healthcare products corporation, as a named Executive Officer and the Senior Vice President, Business Development and Strategy. He was responsible for corporate strategy and global M&A activities.

Previous to this role, he served as BD’s Worldwide President, BD Biosciences, a 3,000 person, US $1.4 billion segment, responsible for its three business units: Cell Analysis, Discovery Labware and Advanced Bioprocessing. Prior to assuming that role, he was President, Cell Analysis, and before that, VP of Business Development and Strategic Investments, where he held worldwide responsibility for business development activities. He also formed and managed BD Ventures L.L.C., the corporate venture capital fund operated by BD.

Prior to joining BD, Mr. Rhodes held various senior executive roles in business development and technology, for Pfizer, Johnson and Johnson and The William James Company.
Mr. Rhodes also currently serves as Senior Executive in Residence at Cornell University, where he identifies university-based technologies appropriate for business formation, and mentors entrepreneurs. In addition, he is a Clinical Instructor with the Weill Cornell Medical College’s Department of Public Health.